MMJ Doctor's Qualifying Condition Note

Specialty: Accident and Emergency Nurse Subjective: Patient is a 45-year-old female with a past medical history significant for chronic neuropathic pain following a motor vehicle accident 5 years prior, and associated anxiety. She is seeking renewal of her medical cannabis certification. The patient reports that cannabis significantly helps manage her chronic neuropathic pain, reducing its intensity from an 8/10 to a 3/10 on average. She also finds it effective in reducing her anxiety levels, allowing for better sleep and improved mood. She has been using cannabis for pain and anxiety relief for the past 3 years, experiencing consistent symptom improvement. Prior to cannabis, her pain was debilitating, and her anxiety often led to panic attacks. Since starting, she has noticed a significant reduction in both frequency and severity of these symptoms. The patient denies any history of CHF, schizophrenia, bipolar disorder, or use of anticoagulants. She reports no allergic reactions to cannabis or cannabis products. Cannabis was initially recommended by a pain management specialist due to inadequate relief from conventional medications. She has held a valid medical marijuana certification for the past 3 years. The patient reports a good tolerance to medical marijuana, with no significant adverse effects experienced. Her preferred method of consumption is vaporisation, which she finds effective and less irritating to her respiratory system compared to smoking. She has also occasionally used edibles for longer-lasting relief, particularly at night. Clinical rationale for continued medical marijuana use includes effective pain management for her chronic neuropathic pain, significant mood stabilisation by reducing anxiety, and improved sleep quality. These are directly related to her qualifying conditions. Counselling was provided regarding cannabis use during pregnancy and breastfeeding. The patient confirmed she is not pregnant and is not breastfeeding, and acknowledged the advice to discontinue all cannabis products if pregnancy occurs or breastfeeding begins in the future. Counselling regarding adolescent cannabis use was provided, covering information about brain development continuing until age 25 and the associated risks. The patient acknowledged and understood these risks, confirming no adolescents reside in her household. The patient expresses a strong desire to continue her medical marijuana treatment due to its demonstrated efficacy in managing her chronic conditions. The patient desires continued access to various forms of medical marijuana, including whole-plant raw cannabis for vaporisation. She was counselled on the risks of smoking cannabis and acknowledged these. Alternative methods such as roasting or vaporising to reduce unwanted effects were discussed, and she confirmed her preference for vaporisation. The legally allowable dosage was discussed, including the quantity per time period and the maximum allowable by law in her state (e.g., 2.5 ounces of usable cannabis per 14-day period). The patient understood these limitations. All topics discussed and questions answered, including acknowledgement of contaminant risks, respiratory health information, health risks of second and third-hand smoke to household members (though none are present), dangers of smoking marijuana in households where oxygen is in use (not applicable), and self-dosing guidance. The patient expressed understanding of all information. The patient reports her current functional status is significantly improved, allowing her to participate in daily activities with much less pain and anxiety. She continues to experience symptom improvement with medical cannabis. Discussion included combination dosing strategies, such as the "Tag Team Effect," where she uses quick-onset vaporisation for immediate relief during the day and longer-duration edibles before bed for sustained effects throughout the night.